Prevalence of Intestinal Parasitic Infections in Patients With Irritable Bowel Syndrome
- Disease/Condition
- Irritable Bowel Syndrome
- Study type
- Observational
- Primary sponsor
- Sohag University
- Location
- Sohag, Egypt
- Phase
- N/A
- Start date
- May 01, 2023
- End date
- Jan 01, 2024
- Enrollment
- 200 participants
To detect prevalence of intestinal parasitic infections in irritable bowel syndrome patients in sohag.
Irritable bowel syndrome (IBS) is common medical disorder and represent a group of diseases
 of the gastrointestinal tract that is characterized by chronic abdominal pain , bloating ,
 passage of mucus or straining with bowel movements, sense of incomplete evacuation after
 bowel movements or sense of urgency to move the bowels.Several parasites including Entamoeba.
 histolytica, Giardia spp., Blastocystis. hominis, and Trichinella spp. have been discussed as
 contributing factors to the development of IBS.
 
 B. hominis is one of the most common human intestinal protozoa in both developing and
 developed countries. some studies have reported a significant association between the
 parasitic infections, especially Blastocystis, and IBS.Cryptosporidium has been reported in
 IBS patients, with the onset of gastrointestinal symptoms after an acute episode of
 cryptosporidiosis despite recovery and parasite clearance.Numerous studies have been
 conducted to evaluate the association between the parasitic infections and IBS.
 
 Aim of the work:
 
 To detect prevalence of intestinal parasitic infections in irritable bowel syndrome patients
 in sohag.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05830370
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT05830370 through Pure Global AI's free database. This phase not specified trial is sponsored by Sohag University and is currently Recruiting. The study focuses on Irritable Bowel Syndrome. Target enrollment is 200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.